Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Total Liabilities: 2009-2024

Historic Total Liabilities for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to $53.0 million.

  • Cumberland Pharmaceuticals' Total Liabilities fell 23.30% to $40.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.1 million, marking a year-over-year decrease of 23.30%. This contributed to the annual value of $53.0 million for FY2024, which is 0.99% up from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' Total Liabilities is $53.0 million, which was up 0.99% from $52.5 million recorded in FY2023.
  • Cumberland Pharmaceuticals' 5-year Total Liabilities high stood at $57.0 million for FY2022, and its period low was $41.9 million during FY2021.
  • Moreover, its 3-year median value for Total Liabilities was $53.0 million (2024), whereas its average is $54.2 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first declined by 15.59% in 2021, then surged by 36.06% in 2022.
  • Cumberland Pharmaceuticals' Total Liabilities (Yearly) stood at $49.6 million in 2020, then decreased by 15.59% to $41.9 million in 2021, then skyrocketed by 36.06% to $57.0 million in 2022, then declined by 7.79% to $52.5 million in 2023, then climbed by 0.99% to $53.0 million in 2024.